U.S. Supreme Court to hear Merck appeal on Vioxx investor suit
Financial24 (Free subscription) | 05/26/2009
WASHINGTON The U.S Supreme Court said on Tuesday that it would hear an appeal by Merck & Co Inc 3 Vote(s)
Merck and Co. Inc.
3Vote!
5Vote!
U.S. Supreme Court to hear Merck appeal on Vioxx investor suit
Reuters (Free subscription) | 05/26/2009
WASHINGTON (Reuters) - The U.S. Supreme Court said on Tuesday that it would hear an appeal by Merck & Co Inc of a ruling that reinstated a securities fraud lawsuit involving the company's disclosures to investors about its withdrawn Vioxx pain drug.
Videos
3Vote!
Nurses paid to scout for Vioxx drug firm
Mission & Justice (Free subscription) | 05/19/2009
Milanda Rout; 19/5/09 Australian marketing staff from pharmaceutical giant Merck & Co paid specialist nurses half-a-million dollars to “hunt” through patient records for potential candidates for their blockbuster anti-arthritis drug Vioxx. The Federal Court was told the company aimed to identify 100 patients of each targeted general practitioner who were not taking Vioxx and could be...
1Vote!
New Survey Of GPs Reveals Support For Continued Focus On Cholesterol-lowering In QOF1, UK
Medical News Today (Free subscription) | 05/18/2009
The results of a new survey of 400 UK healthcare professionals, conducted by TNS Healthcare UK and sponsored by Merck Sharp & Dohme Limited and Schering-Plough Limited, reveal that the majority of GPs surveyed (82% of the 100 GPs) believe that the cholesterol indicator (CHD 08) should remain a priority area in the Quality and Outcomes Framework (QOF).
1Vote!
Fat cat special - Big Pharma CEO pay
PharmaGossip (Free subscription) | 05/18/2009
1. Bill Weldon - Johnson & Johnson - $29.4M 2. Miles White - Abbott Laboratories - $28.3M 3. Bernard Poussot - Wyeth - $25M 4. Jim Cornelius - Bristol-Myers Squibb - $25M 5. Richard Clark - Merck - $19.9M 6. Robert Parkinson - Baxter International - $16M 7. David Vasella - Novartis - $15.1M 8. Jeffrey Kindler - Pfizer - $14.8M 9. Frank Baldino - Cephalon - $14.5M 10. John Lechleiter - Eli Lilly...
4Vote!
Drug Company Had Hit List for Doctors Who Criticized Them
Alex Constantine's Blacklist (Free subscription) | 05/16/2009
Dr. Mercola articles.mercola.com April 23 2009 The international drug company Merck had a hit list of doctors who had to be "neutralized" or discredited because they had criticized the painkiller Vioxx, a now-withdrawn drug that the pharmaceutical giant produced. Staff at the company emailed each other about the list of doctors. The email, which came out during a class-action suit against...
3Vote!
Medical manoeuvres of Vioxx representatives revealed
Mission & Justice (Free subscription) | 05/16/2009
Milanda Rout; 16/5/09 Australian sales staff of the pharmaeutical giant that produced anti-arthritis drug Vioxx were trained to get past “difficult” receptionists so they could spruik their products to doctors. The Federal Court was told Merck, Sharp and Dohme taught its sales representatives how to deal with receptionists at medical clinics who would not let them [...]
7Vote!
Mercketing
Concurring Opinions (Free subscription) | 05/16/2009
In an era of information overload, how can a drug marketer get its message across? One new method is creating its very own “journal”, as Merck and Elsevier did in Australia: From 2002 through 2005, the Australian affiliate of Merck paid the Australian office of Elsevier, an academic publisher, to publish eight compilations of scientific articles under the title Australasian Journal of...
1Vote!
Anaphore rakes in $13M in second VC closing
Fiercebiotech (Free subscription) | 05/15/2009
Less than a month after announcing an $8 million closing , San Diego, CA-based start-up Anaphore has pulled in another $13 million and three new investors. This brings the total proceeds for its series A venture round to $38 million. New investors SR One, Merck Serono Ventures and Aravis have joined existing investors 5AM Ventures, Versant Ventures and Apposite Capital. The funds will be used to advance...
1Vote!
Elsevier Journal Scandal Provokes Significant Librarian Response
Library Stuff (Free subscription) | 05/15/2009
Library Journal - “Since word of Elsevier's publication of a “fake” journal sponsored by pharmaceutical company Merck spread last week, the company acknowledged the publication of five more journals with similar undisclosed sponsorship between 2000 and 2005. (This publication and Elsevier have the same parent company, Reed Elsevier.)”
4Vote!
Merck Serono Champions Personalized Cancer Care With Targeted Therapies
Business Wire (Free subscription) | 05/15/2009
DARMSTADT, Germany--(BUSINESS WIRE)--Merck Serono, a division of Merck KGaA, Darmstadt, Germany, leads the way in personalizing cancer care with new potential targeted treatment options that benefit an ever-widening
Explore : Health Industries
6Vote!
Manufacturing Truth
Futurelab (Free subscription) | 05/14/2009
by: Jonathan Salem Baskin The Scientist magazine reported last week that pharma giant Merck had invented its own peer review medical journal in order to better hype its products; of 29 articles, almost two-thirds referred to Fosamax or Vioxx. And we're surprised?
1Vote!
Cutting Edge Information: Outcomes-Based Pricing Agreements Between Pharma and Managed Care Organizations Are on the Rise, Says Cutting Edge Information
Market Wire (Free subscription) | 05/14/2009
RESEARCH TRIANGLE PARK, NC (MARKET WIRE) The recent agreements between Merck and Cigna, as well as Sanofi-Aventis, Procter & Gamble and Health Alliance, signify a major shift in the pharmaceutical industry's approach to gathering and using health outcomes data, according to Cutting Edge Information.
7Vote!
"Trial Puts Spotlight on Merck"
How Appealing (Free subscription) | 05/14/2009
"Trial Puts Spotlight on Merck": Today's edition of The New York Times contains an article that begins, "Australians have been riveted over the last month by a class-action lawsuit that is pulling back the curtain on strategies that the American...
7Vote!
Civil Suit Uncovers Fake Journals to Promote Vioxx
ABC News (Free subscription) | 05/14/2009
Testimony accuses drugmaker Merck of paying for scientific journal lookalikes.
The 2 latest articles published by users on Merck and Co. Inc. :
2Vote!
Zetia Tablets 10mg
drterry | 03/25/2009
Here you will find information that is free for Zetia Tablets 10mg. The program Zetia Patient Assistance Program controlled (or directed) by Merck & Company , Inc. distributes this drug to qualified patients after acceptance is given. Why do Canadian prescription drugs when these are free. Observe the "controlling directives/guidelines" then proceed towards applying to the free prescription medicine...
1Vote!
Merck, Schering-Plough merger highlights industry
anonymous (Free subscription) | 03/10/2009
Drugmakers Merck & Co. and Schering-Plough Corp. are planning to merge under the name Merck in a stock-and-cash deal worth about $41.1, If Merck merges with Schering-Plough , could Johnson & Johnson gain control of Schering’s blockbuster drug Remicade?, And much Details here. Source page : http://time2masti.blogspot.com/2009/03/merck-schering-plough-merger.html